JP2017519046A - 甘味受容体アンタゴニスト組成物 - Google Patents
甘味受容体アンタゴニスト組成物 Download PDFInfo
- Publication number
- JP2017519046A JP2017519046A JP2017517220A JP2017517220A JP2017519046A JP 2017519046 A JP2017519046 A JP 2017519046A JP 2017517220 A JP2017517220 A JP 2017517220A JP 2017517220 A JP2017517220 A JP 2017517220A JP 2017519046 A JP2017519046 A JP 2017519046A
- Authority
- JP
- Japan
- Prior art keywords
- zinc
- gymnemic acid
- composition
- acid
- sweetness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 124
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 229930183009 gymnemic acid Natural products 0.000 claims abstract description 177
- 235000019658 bitter taste Nutrition 0.000 claims abstract description 65
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 54
- 239000011701 zinc Substances 0.000 claims abstract description 47
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 32
- 235000009508 confectionery Nutrition 0.000 claims abstract description 20
- 235000019577 caloric intake Nutrition 0.000 claims abstract description 7
- 239000003112 inhibitor Substances 0.000 claims description 36
- 150000003839 salts Chemical class 0.000 claims description 36
- 239000002253 acid Substances 0.000 claims description 33
- 239000012453 solvate Substances 0.000 claims description 13
- -1 zinc halide Chemical class 0.000 claims description 12
- 101710084933 Miraculin Proteins 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 8
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 8
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 8
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- 239000006191 orally-disintegrating tablet Substances 0.000 claims description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 8
- 239000011670 zinc gluconate Substances 0.000 claims description 8
- 235000011478 zinc gluconate Nutrition 0.000 claims description 8
- 229960000306 zinc gluconate Drugs 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000007937 lozenge Substances 0.000 claims description 7
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 7
- 229960001763 zinc sulfate Drugs 0.000 claims description 7
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 7
- 229920000858 Cyclodextrin Polymers 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 5
- NLMDJJTUQPXZFG-UHFFFAOYSA-N 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane Chemical compound C1COCCOCCNCCOCCOCCN1 NLMDJJTUQPXZFG-UHFFFAOYSA-N 0.000 claims description 4
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims description 4
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 4
- 239000002739 cryptand Substances 0.000 claims description 4
- 239000007919 dispersible tablet Substances 0.000 claims description 4
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 4
- 235000015110 jellies Nutrition 0.000 claims description 4
- 239000008274 jelly Substances 0.000 claims description 4
- 239000000668 oral spray Substances 0.000 claims description 4
- 159000000000 sodium salts Chemical group 0.000 claims description 4
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 4
- 239000004246 zinc acetate Substances 0.000 claims description 4
- 235000013904 zinc acetate Nutrition 0.000 claims description 4
- 239000011667 zinc carbonate Substances 0.000 claims description 4
- 235000004416 zinc carbonate Nutrition 0.000 claims description 4
- 229910000010 zinc carbonate Inorganic materials 0.000 claims description 4
- 239000011592 zinc chloride Substances 0.000 claims description 4
- 235000005074 zinc chloride Nutrition 0.000 claims description 4
- 239000011746 zinc citrate Substances 0.000 claims description 4
- 235000006076 zinc citrate Nutrition 0.000 claims description 4
- 229940068475 zinc citrate Drugs 0.000 claims description 4
- PENRVBJTRIYHOA-UHFFFAOYSA-L zinc dithionite Chemical compound [Zn+2].[O-]S(=O)S([O-])=O PENRVBJTRIYHOA-UHFFFAOYSA-L 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- ZTUVUXVSZXNSCL-UHFFFAOYSA-L zinc;hydrogen sulfite Chemical compound [Zn+2].OS([O-])=O.OS([O-])=O ZTUVUXVSZXNSCL-UHFFFAOYSA-L 0.000 claims description 4
- 102000004895 Lipoproteins Human genes 0.000 claims description 3
- 108090001030 Lipoproteins Proteins 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 3
- 229960000314 zinc acetate Drugs 0.000 claims description 3
- 229940043825 zinc carbonate Drugs 0.000 claims description 3
- 229960001939 zinc chloride Drugs 0.000 claims description 3
- ZULTYUIALNTCSA-UHFFFAOYSA-N zinc hydride Chemical compound [ZnH2] ZULTYUIALNTCSA-UHFFFAOYSA-N 0.000 claims description 3
- 229910000051 zinc hydride Inorganic materials 0.000 claims description 3
- 208000002925 dental caries Diseases 0.000 claims description 2
- 229940041678 oral spray Drugs 0.000 claims 2
- 210000000214 mouth Anatomy 0.000 abstract description 42
- 230000000903 blocking effect Effects 0.000 abstract description 9
- 230000002035 prolonged effect Effects 0.000 abstract description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 21
- 229930006000 Sucrose Natural products 0.000 description 21
- 239000005720 sucrose Substances 0.000 description 21
- 229960004793 sucrose Drugs 0.000 description 21
- MIEKOFWWHVOKQX-UHFFFAOYSA-N (S)-2-(4-Methoxyphenoxy)propanoic acid Chemical group COC1=CC=C(OC(C)C(O)=O)C=C1 MIEKOFWWHVOKQX-UHFFFAOYSA-N 0.000 description 15
- 235000013305 food Nutrition 0.000 description 13
- 230000005764 inhibitory process Effects 0.000 description 13
- 235000019605 sweet taste sensations Nutrition 0.000 description 13
- 108020003175 receptors Proteins 0.000 description 12
- 102000005962 receptors Human genes 0.000 description 12
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 230000008447 perception Effects 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 238000001223 reverse osmosis Methods 0.000 description 9
- 230000001629 suppression Effects 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 8
- 108091005708 gustatory receptors Proteins 0.000 description 8
- 241000208251 Gymnema Species 0.000 description 7
- 150000003863 ammonium salts Chemical class 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 150000003751 zinc Chemical class 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 239000008122 artificial sweetener Substances 0.000 description 4
- 235000021311 artificial sweeteners Nutrition 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 235000021147 sweet food Nutrition 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 3
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 210000000108 taste bud cell Anatomy 0.000 description 3
- 150000008130 triterpenoid saponins Chemical class 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- 239000001096 (4-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol hydrochloride Substances 0.000 description 2
- NNKXWRRDHYTHFP-HZQSTTLBSA-N (r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydron;dichloride Chemical compound Cl.Cl.C([C@H]([C@H](C1)C=C)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 NNKXWRRDHYTHFP-HZQSTTLBSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 241000208253 Gymnema sylvestre Species 0.000 description 2
- 101000659765 Homo sapiens Taste receptor type 1 member 2 Proteins 0.000 description 2
- 101000659774 Homo sapiens Taste receptor type 1 member 3 Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 102100035948 Taste receptor type 1 member 2 Human genes 0.000 description 2
- 102100035942 Taste receptor type 1 member 3 Human genes 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000021472 generally recognized as safe Nutrition 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229960001811 quinine hydrochloride Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000002105 tongue Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 235000012431 wafers Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical compound C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 description 1
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Chemical class 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 206010056465 Food craving Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical class NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-O Methylammonium ion Chemical compound [NH3+]C BAVYZALUXZFZLV-UHFFFAOYSA-O 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 108010039918 Polylysine Chemical class 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- VWTINHYPRWEBQY-UHFFFAOYSA-N denatonium Chemical compound [O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C VWTINHYPRWEBQY-UHFFFAOYSA-N 0.000 description 1
- 229960001610 denatonium benzoate Drugs 0.000 description 1
- 229960001985 dextromethorphan Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002714 polyornithine Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- SKORRGYRKQDXRS-UHFFFAOYSA-M sodium;2-(4-methoxyphenoxy)propanoate Chemical compound [Na+].COC1=CC=C(OC(C)C([O-])=O)C=C1 SKORRGYRKQDXRS-UHFFFAOYSA-M 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 235000019208 sweet taste inhibitor Nutrition 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
- 239000006068 taste-masking agent Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 108010063331 type 2 taste receptors Proteins 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/362—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/38—Sucrose-free products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/86—Addition of bitterness inhibitors
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/16—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by heating loose unpacked materials
- A23L3/18—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by heating loose unpacked materials while they are progressively transported through the apparatus
- A23L3/20—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by heating loose unpacked materials while they are progressively transported through the apparatus with transport along plates
- A23L3/205—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by heating loose unpacked materials while they are progressively transported through the apparatus with transport along plates in solid state
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/312—Foods, ingredients or supplements having a functional effect on health having an effect on dental health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
- A23V2200/3322—Low carb - reduced carbohydrate content
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本出願は、米国特許法第119条(e)により、2014年6月12日に出願された米国特許仮出願第62/011,096号および2014年7月17日に出願された米国特許仮出願第62/025,725号の優先権を主張する。これらはともに、参照により本明細書に組み込まれる。
配合物FLLC−F27c 4mg(長期放出配合物)
活性剤と1グラムのエリトリトールおよびグルコン酸亜鉛を共ミリングし、均一な微粉末にする。 残りの賦形剤を30メッシュスクリーンに通して分級する。次いで、ステアリン酸マグネシウム以外のすべての賦形剤を合わせる。
ステアリン酸マグネシウムを添加する
1分間ブレンドする
配合物を錠剤に圧縮する
本発明のギムネマ酸組成物の甘味ブロックの持続時間を定量するための標準方法を開発した。以下の実施例で使用したギムネマ酸は、ホウライアオカズラ(Gymnema sylvestre)の葉の粗製エキスを部分精製したものであり、ギムネマ酸の混合物(81%純度)であると測定され、この混合物は主にGA1とGA2であり、これより少ない量のGA3とGA4を有し、また、GAの酢酸/安息香酸ジエステル(即ち、GA34−ギムネモシドC)も含むものであった。すべての場合で、ショ糖を甘味ブロックの定量における甘味物質として使用した。従って、10%、8%、6%、4%および2%(w/v)のショ糖の逆浸透(RO)精製水中の溶液を、各実験の開始毎に新たに調製し、各ショ糖溶液の15mLのサンプルを甘味度の官能試験パネリストの較正に使用した。官能試験パネリストは、味覚(gustatation)の分野の官能評価の訓練を受け、官能試験パネリストとして少なくとも1年間の経験を有する人、好ましくは記述的分析の訓練を受けている人と説明される。甘味度(SI)の定量には、以下の評価段階:
10%ショ糖=10、
8%ショ糖=8、
6%ショ糖=6、
4%ショ糖=4、
2%ショ糖=2および
0%ショ糖=0
に基づいた標準的な段階評価方法論を使用した。
以下の本発明の実施例との比較対象のベースライン値を調べるため、ギムネマ酸を、この甘味抑制の持続時間を定量するために評価した。得られた結果を表1にまとめる。
ギムネマ酸との併用での潜在価値を調べるため、ラクチゾールを、この甘味抑制の持続時間を定量するために評価した。ラクチゾールは甘さブロッカーとしてギムネマ酸とは異なり、例えば、ラクチゾールによってもたらされる甘さブロックは、舌に曝露された後は長く続かない。しかしながら、驚くべきことに、口腔がラクチゾールに曝露された後、ラクチゾールを吐き出した後、即座に10%ショ糖参照をテイスティングした場合であっても甘味抑制は観察されないことが観察された。
ギムネマ酸(15mg)とラクチゾール(3mg)のブレンドの甘さ抑制
ギムネマ酸/ラクチゾールブレンドを、この甘味抑制の持続時間を定量するために評価した。得られた結果を表3にまとめる。
ギムネマ酸との併用での潜在価値を調べるため、ZnSO4・7H2Oを、この甘味抑制の持続時間を定量するために評価した。驚くべきことに、ZnSO4・7H2Oは、ギムネマ酸と同様、長時間の甘味抑制を引き起こしたが、甘さの感度が100%に回復したのは60分後であったため、ギムネマ酸の場合に近いほどは長時間でないことが観察された。得られた結果を表4にまとめる。
ギムネマ酸(15mg)とZnSO4・7H2O(107mg)のブレンドの甘さ抑制
次いで、ギムネマ酸/ZnSO4・7H2Oのブレンドを、甘味ブロックの持続時間について評価した。結果を表5にまとめる。
ギムネマ酸との併用での潜在価値を調べるため、ミラクリンを、この甘味抑制の持続時間を定量するために評価した。ミラクリンでの口腔の前処理後、甘味抑制効果は観察されなかった。得られた結果を表6にまとめる。
ギムネマ酸(15mg)とミラクリン(80mg)のブレンドの甘さ抑制
甘味抑制効果は観察されないにもかかわらず、それでもなお、ミラクリンをギムネマ酸との併用において評価し、ギムネマ酸の甘味抑制の持続時間が引き延ばされることが観察され得るかどうかを調べた。ミラクリンは、ギムネマ酸の甘味ブロックの持続時間を引き延ばすことが観察された。このため、ギムネマ酸と併用したミラクリンでは、甘味に対する相乗的抑制効果がもたらされる。結果を表7にまとめる。
ギムネマ酸(15mg)、ラクチゾール(3mg)およびZnSO4・7H2O(107mg)のブレンドの甘さ抑制
上記で実証されたように、ラクチゾールおよびZnSO4・7H2Oを独立して、ギムネマ酸と併用して使用した場合、甘さ抑制において相乗作用を示す。ギムネマ酸と併用したこれらの甘味抑制剤の両方を含有する3成分ブレンド組成物を評価し、相乗作用の増大が存在し得るかどうかを調べた。結果を表8にまとめる。
15mgのギムネマ酸の15mLのRO水中の溶液を評価し、苦さの15段階評価段階で10の苦さスコアを有することがわかった。
ギムネマ酸(15mg)とZnSO4・7H2O(107mg)のブレンドの苦さ
15mgのギムネマ酸の10mLのRO水中の溶液を107mgのZnSO4・7H2Oの5mLのRO水中の溶液と合わせ、評価した。0の苦さスコアを有することがわかった。それぞれ60、34、19、10.7、6および3.4mgのZnSO4・7H2Oを5mLのRO水中に含む水溶液を15mgのギムネマ酸(10mLのRO水サンプル中)と合わせた。得られた混合物は、それぞれ0、0、0、1、4および7の苦さ強度を示した。従って、このようなギムネマ酸/ZnSO4・7H2O組成物は、ZnSO4・7H2O濃度がおよそ0.6mg/mL(2mM)以上である場合、苦さがなくなることを示している。
Claims (25)
- ギムネマ酸および少なくとも1種類の形態の亜鉛を含む組成物。
- 送達形態が、ロゼンジ剤、口腔内崩壊錠、口腔内分散錠、トローチ、ハードキャンディ、ソフトキャンディ、ゼリー、ガム、可食フィルム、口腔内溶解性フィルム剤、ウエハース、ドロップ、オーラルスプレー、液剤、粉剤およびこの組合せからなる群より選択される、請求項1に記載の組成物。
- 送達形態が、約30秒から約5分間の範囲の崩壊時間を有する口腔内崩壊錠である、請求項2に記載の組成物。
- 該亜鉛の形態が、酢酸亜鉛、炭酸亜鉛、塩化亜鉛、クエン酸亜鉛、グルコン酸亜鉛、硫酸亜鉛、亜ジチオン酸亜鉛、重亜硫酸亜鉛、酸化亜鉛、ハロゲン化亜鉛、水素化亜鉛、炭化亜鉛およびこの組合せからなる群より選択される、請求項1に記載の組成物。
- 該亜鉛の形態がグルコン酸亜鉛である、請求項1に記載の組成物。
- ギムネマ酸が、ギムネマ酸の無機塩、ギムネマ酸の有機塩、ギムネマ酸のシクロデキストリン錯体、ギムネマ酸のクリプタンド錯体、ギムネマ酸の水和物、ギムネマ酸の溶媒和物およびこの組合せからなる群より選択される、請求項1に記載の組成物。
- ギムネマ酸の溶媒和物が、ギムネマ酸のエタノール溶媒和物およびこの組合せからなる群より選択される、請求項5に記載の組成物。
- 送達形態が、さらにミントを含んでもよい、請求項1に記載の組成物。
- 送達形態が、さらに苦味抑制剤を含んでもよく、該苦味抑制剤が、ナトリウム塩、リポタンパク質およびこの組合せからなる群より選択される、請求項1に記載の組成物。
- さらに少なくとも1種類の酸味抑制剤を含む、請求項1に記載の組成物。
- 少なくとも1種類の酸味抑制剤がミラクリンである、請求項8に記載の組成物。
- 請求項1に記載の組成物を含む舌上送達形態。
- 送達形態が、ロゼンジ剤、口腔内崩壊錠、口腔内分散錠、トローチ、ハードキャンディ、ソフトキャンディ、ゼリー、ガム、可食フィルム、口腔内溶解性フィルム剤、ウエハース、ドロップ、オーラルスプレー、液剤、粉剤およびこの組合せからなる群より選択される、請求項12に記載の舌上送達形態。
- 送達形態が、約30秒から約5分間の範囲の崩壊時間を有する口腔内崩壊錠である、請求項13に記載の舌上送達形態。
- 該亜鉛の形態が、酢酸亜鉛、炭酸亜鉛、塩化亜鉛、クエン酸亜鉛、グルコン酸亜鉛、硫酸亜鉛、亜ジチオン酸亜鉛、重亜硫酸亜鉛、酸化亜鉛、ハロゲン化亜鉛、水素化亜鉛、炭化亜鉛およびこの組合せからなる群より選択される、請求項12に記載の舌上送達形態。
- 該亜鉛の形態がグルコン酸亜鉛である、請求項12に記載の組成物。
- ギムネマ酸が、ギムネマ酸の無機塩、ギムネマ酸の有機塩、ギムネマ酸のシクロデキストリン錯体、ギムネマ酸のクリプタンド錯体、ギムネマ酸の水和物、ギムネマ酸の溶媒和物およびこの組合せからなる群より選択される、請求項12に記載の組成物。
- ギムネマ酸の溶媒和物が、ギムネマ酸のエタノール溶媒和物およびこの組合せからなる群より選択される、請求項17に記載の組成物。
- 送達形態が、さらにミントを含んでもよい、請求項12に記載の組成物。
- 送達形態が、さらに苦味抑制剤を含んでもよく、該苦味抑制剤が、ナトリウム塩、リポタンパク質およびこの組合せからなる群より選択される、請求項12に記載の組成物。
- さらに少なくとも1種類の酸味抑制剤を含む、請求項12に記載の組成物。
- 少なくとも1種類の酸味抑制剤がミラクリンである、請求項21に記載の組成物。
- 請求項1に記載の組成物を被験体に投与することを含む、砂糖消費量の低減方法。
- 請求項1に記載の組成物を被験体に投与することを含む、カロリー摂取量の低減方法。
- 請求項1に記載の組成物を被験体に投与することを含む、虫歯の低減方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462011096P | 2014-06-12 | 2014-06-12 | |
US62/011,096 | 2014-06-12 | ||
US201462025725P | 2014-07-17 | 2014-07-17 | |
US62/025,725 | 2014-07-17 | ||
PCT/US2015/035578 WO2015192015A2 (en) | 2014-06-12 | 2015-06-12 | Sweet taste receptor antagonist compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2017519046A true JP2017519046A (ja) | 2017-07-13 |
Family
ID=54545455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017517220A Pending JP2017519046A (ja) | 2014-06-12 | 2015-06-12 | 甘味受容体アンタゴニスト組成物 |
Country Status (13)
Country | Link |
---|---|
US (5) | US9421217B2 (ja) |
EP (1) | EP3154518A2 (ja) |
JP (1) | JP2017519046A (ja) |
KR (1) | KR20170020859A (ja) |
CN (1) | CN106659215A (ja) |
AU (1) | AU2015274362A1 (ja) |
BR (1) | BR112016028973A2 (ja) |
CA (1) | CA2953243A1 (ja) |
IL (1) | IL249466A0 (ja) |
MA (1) | MA40227A (ja) |
MX (1) | MX2016016214A (ja) |
SG (1) | SG11201609600UA (ja) |
WO (1) | WO2015192015A2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102628901B1 (ko) * | 2017-06-27 | 2024-01-24 | 더 코카콜라 컴파니 | 구강내 감미제 조성물 및 방법 |
US11484542B2 (en) | 2018-05-30 | 2022-11-01 | Adam Slank | Specialized tongue spray containing gymnemic acid and exogenous ketones |
WO2020208630A1 (en) * | 2019-04-09 | 2020-10-15 | Gyni S.G Ltd | Sweetness blocker composition |
WO2023195718A1 (ko) * | 2022-04-04 | 2023-10-12 | 서울대학교산학협력단 | 감미 억제용 조성물 및 식품의 감미 억제 방법 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63119416A (ja) * | 1986-11-07 | 1988-05-24 | Yasutake Hichi | 抗齲蝕剤 |
JPH0366623A (ja) * | 1989-08-03 | 1991-03-22 | Toreede Uindo Kk | 肥満防止剤及びその製造法 |
JPH07255390A (ja) * | 1994-03-16 | 1995-10-09 | Saken Foods:Kk | ギムネマ・ゼリー |
JP2001069961A (ja) * | 1999-09-02 | 2001-03-21 | Fuji Chem Ind Co Ltd | 苦味マスキング用組成物 |
US20020136782A1 (en) * | 2001-01-18 | 2002-09-26 | Fleischner Albert M. | Composition patent for solid-dosage form of weight loss product |
JP2004149471A (ja) * | 2002-10-31 | 2004-05-27 | Shiratori Pharmaceutical Co Ltd | 血糖低下剤 |
US20050276839A1 (en) * | 2004-06-10 | 2005-12-15 | Rifkin Calman H | Appetite satiation and hydration beverage |
JP2006006251A (ja) * | 2004-06-28 | 2006-01-12 | Sanei Gen Ffi Inc | 食品の呈味改善方法 |
CN101028320A (zh) * | 2006-12-05 | 2007-09-05 | 广州加德恩医药有限公司 | 一种具有降糖降脂作用的植物药组合物及其制备方法 |
EP2243473A1 (en) * | 2009-04-17 | 2010-10-27 | Hexal AG | Tablets comprising a taste masking agent |
CN101999668A (zh) * | 2010-10-11 | 2011-04-06 | 孙羽蒙 | 一种用于治疗糖尿病的组方 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6746695B1 (en) * | 1998-10-02 | 2004-06-08 | Armadillo Pharmaceuticals, Inc. | Pharmaceutical preparations of bioactive substances extracted from natural sources |
US7119110B2 (en) * | 2001-10-05 | 2006-10-10 | Interhealth Nutraceuticals Incorporated | Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
US7273607B2 (en) * | 2002-07-01 | 2007-09-25 | Karl G. Schakel, legal representative | Health enhancement method |
JP3973605B2 (ja) | 2002-07-10 | 2007-09-12 | 東京エレクトロン株式会社 | 成膜装置及びこれに使用する原料供給装置、成膜方法 |
US20060263475A1 (en) * | 2004-08-25 | 2006-11-23 | Cadbury Adams Usa, Llc. | Center-filled chewing gum composition |
US7851005B2 (en) * | 2005-05-23 | 2010-12-14 | Cadbury Adams Usa Llc | Taste potentiator compositions and beverages containing same |
JP4500874B2 (ja) * | 2005-05-23 | 2010-07-14 | キャドバリー アダムス ユーエスエー エルエルシー | 味覚増強剤組成物及び味覚増強剤組成物を含有する飲料 |
US20080241281A1 (en) * | 2007-03-29 | 2008-10-02 | Texas Tech University System | Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development |
KR101751074B1 (ko) * | 2009-02-02 | 2017-06-26 | 크로모셀 코포레이션 | 신규한 세포주와 방법 |
-
2015
- 2015-06-12 CA CA2953243A patent/CA2953243A1/en not_active Abandoned
- 2015-06-12 CN CN201580031394.XA patent/CN106659215A/zh active Pending
- 2015-06-12 JP JP2017517220A patent/JP2017519046A/ja active Pending
- 2015-06-12 WO PCT/US2015/035578 patent/WO2015192015A2/en active Application Filing
- 2015-06-12 AU AU2015274362A patent/AU2015274362A1/en not_active Abandoned
- 2015-06-12 US US14/738,326 patent/US9421217B2/en active Active
- 2015-06-12 SG SG11201609600UA patent/SG11201609600UA/en unknown
- 2015-06-12 KR KR1020177001044A patent/KR20170020859A/ko unknown
- 2015-06-12 BR BR112016028973A patent/BR112016028973A2/pt not_active Application Discontinuation
- 2015-06-12 MX MX2016016214A patent/MX2016016214A/es unknown
- 2015-06-12 MA MA040227A patent/MA40227A/fr unknown
- 2015-06-12 EP EP15795040.3A patent/EP3154518A2/en not_active Withdrawn
-
2016
- 2016-06-27 US US15/194,411 patent/US9585905B2/en active Active
- 2016-12-08 IL IL249466A patent/IL249466A0/en unknown
-
2017
- 2017-02-02 US US15/423,212 patent/US20170143793A1/en not_active Abandoned
-
2018
- 2018-04-05 US US15/946,609 patent/US20190070254A1/en not_active Abandoned
-
2020
- 2020-05-18 US US16/877,272 patent/US20210030839A1/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63119416A (ja) * | 1986-11-07 | 1988-05-24 | Yasutake Hichi | 抗齲蝕剤 |
JPH0366623A (ja) * | 1989-08-03 | 1991-03-22 | Toreede Uindo Kk | 肥満防止剤及びその製造法 |
JPH07255390A (ja) * | 1994-03-16 | 1995-10-09 | Saken Foods:Kk | ギムネマ・ゼリー |
JP2001069961A (ja) * | 1999-09-02 | 2001-03-21 | Fuji Chem Ind Co Ltd | 苦味マスキング用組成物 |
US20020136782A1 (en) * | 2001-01-18 | 2002-09-26 | Fleischner Albert M. | Composition patent for solid-dosage form of weight loss product |
JP2004149471A (ja) * | 2002-10-31 | 2004-05-27 | Shiratori Pharmaceutical Co Ltd | 血糖低下剤 |
US20050276839A1 (en) * | 2004-06-10 | 2005-12-15 | Rifkin Calman H | Appetite satiation and hydration beverage |
JP2006006251A (ja) * | 2004-06-28 | 2006-01-12 | Sanei Gen Ffi Inc | 食品の呈味改善方法 |
CN101028320A (zh) * | 2006-12-05 | 2007-09-05 | 广州加德恩医药有限公司 | 一种具有降糖降脂作用的植物药组合物及其制备方法 |
EP2243473A1 (en) * | 2009-04-17 | 2010-10-27 | Hexal AG | Tablets comprising a taste masking agent |
CN101999668A (zh) * | 2010-10-11 | 2011-04-06 | 孙羽蒙 | 一种用于治疗糖尿病的组方 |
Non-Patent Citations (2)
Title |
---|
ACTA. PHYSIOL. SCAND., vol. 124, JPN6019007655, 1985, pages 399 - 408, ISSN: 0004143324 * |
BRALA P M; HAGEN R L: "EFFECTS OF SWEETNESS PERCEPTION AND CALORIC VALUE OF A PRELOAD ON SHORT TERM INTAKE", PHYSIOLOGY AND BEHAVIOR, vol. VOL:30, NR:1, JPN5017004740, 1983, GB, pages 1 - 9, ISSN: 0004143325 * |
Also Published As
Publication number | Publication date |
---|---|
EP3154518A2 (en) | 2017-04-19 |
CA2953243A1 (en) | 2015-12-17 |
US20150359809A1 (en) | 2015-12-17 |
US9421217B2 (en) | 2016-08-23 |
MX2016016214A (es) | 2017-08-02 |
US20210030839A1 (en) | 2021-02-04 |
AU2015274362A1 (en) | 2016-12-08 |
WO2015192015A3 (en) | 2016-02-04 |
US20190070254A1 (en) | 2019-03-07 |
BR112016028973A2 (pt) | 2017-08-22 |
WO2015192015A2 (en) | 2015-12-17 |
MA40227A (fr) | 2017-04-19 |
US20160303149A1 (en) | 2016-10-20 |
SG11201609600UA (en) | 2016-12-29 |
IL249466A0 (en) | 2017-02-28 |
US9585905B2 (en) | 2017-03-07 |
CN106659215A (zh) | 2017-05-10 |
KR20170020859A (ko) | 2017-02-24 |
US20170143793A1 (en) | 2017-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210030839A1 (en) | Sweet taste receptor antagonist compositions | |
EP3264917B1 (en) | Rebaudioside-d containing sweetener compositions | |
US20150272184A1 (en) | Naringenin and salts thereof for sweetness enhancement | |
CN112261879A (zh) | 用于增强甜度的毛蕊花糖苷及其相关化合物 | |
JP2005336078A (ja) | マスキング剤 | |
JP2002363105A (ja) | 不快な味のマスキング方法及び内服用液剤 | |
US20210177023A1 (en) | Compounds for sweetness enhancement | |
JP2010280645A (ja) | γ−アミノ酪酸含有経口用組成物 | |
US8455024B2 (en) | Appetite suppressant composition | |
US20160271199A1 (en) | Taste Modifiers and Therapeutic Methods Thereof | |
EP3181150A1 (de) | Pharmazeutische zubereitungen | |
JP2005073588A (ja) | サポニン含有経口製品およびサポニンの不快味低減方法 | |
JP2021505151A (ja) | 甘味料としてのトリプトファン誘導体 | |
JP7369931B2 (ja) | 風邪症状緩和用飲食品組成物 | |
GB2623801A (en) | Composition and method for reducing negative taste sensations of propolis preparations | |
NZ735127B2 (en) | Rebaudioside-d containing sweetener compositions | |
JPH0952849A (ja) | 感冒剤用組成物 | |
JP2008024675A (ja) | 内服液剤組成物 | |
JP2009149578A (ja) | 内服用組成物 | |
JP2019135995A (ja) | 甘味料用異味改善剤 | |
JP2007215407A (ja) | セラミド類含有食品及び内服剤 | |
JP2003055194A (ja) | 内服用液剤 | |
JP2010280631A (ja) | 内用液剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180605 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190305 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190603 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20191105 |